Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Liana Martínez Pérez"'
Autor:
Mayelin Troche Concepción, Beatriz García Verdecia, Elia Neninger Vinagera, Gonzalez Marinello Gisela Maria, Jean-François Dupuy, Bárbara Wilkinson Brito, Tania Crombet-Ramos, Camilo Rodríguez, Martha Fors López, Liana Martínez Pérez, Carmen Viada González, Patricia Lorenzo Luaces
Publikováno v:
Journal of Cancer Therapy. :8-14
Background: The Center of Molecular Immunology (CIM) is a center in Cuba devoted to the research, development and manufacturing of biotechnological products. CIMAvax?EGF is a vaccine for the treatment of non-small cell lung cancer patients (NSCL). Pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ab9e5f42bba7a73267bc82319590f27
https://doi.org/10.4236/jct.2013.48a002
https://doi.org/10.4236/jct.2013.48a002
Autor:
Maylén Acosta Martínez, María Esther Valencia Jarvis, Aliuska Frías Blanco, Carmen Viada González, Bárbara Wilkinson Brito, Mayra Ramos Suzarte, Olga Torres Gemeil, Natacha Valencia Jarvis, Eduardo Corrales Reyna, Liana Martínez Pérez, Mayelin Troche Concepción, Yanela Santiesteban González, Daylis Rodríguez Valdés
Publikováno v:
Revista Cubana de Salud Pública. 36:285-288
El Centro de Inmunologia Molecular ha venido desarrollando biomoleculas para el tratamiento del cancer. En la medida que se avanza en el desarrollo de estos productos, se avanza en las fases I, II, III y IV de los ensayos clinicos, lo que trae aparej
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ede76b5db4d9f52fe8d7d6ff73d76e3
https://doi.org/10.1590/s0864-34662010000300019
https://doi.org/10.1590/s0864-34662010000300019
Autor:
Elia Neninger Vinageras, Liana Martínez Pérez, Idrissa Leonard Rupalé, Beatriz García Verdecia, Agustín Lage Dávila, Gonzalez Marinello Gisela Maria, Mauricio Catala Ferrer, Tania Crombet Ramos, Rolando Pérez Rodríguez
Publikováno v:
Cancer Biology & Therapy. 5:145-149
Epidermal Growth Factor (EGF) promotes tumor cell proliferation and survival upon binding to its receptor. We have developed a new active specific immunotherapy based on EGF deprivation. In the present paper, we show the results of a Phase I trial in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e554bb0d790bf70516d167b0e76a92
https://doi.org/10.4161/cbt.5.2.2334
https://doi.org/10.4161/cbt.5.2.2334
Autor:
Carmen Viada González, Tatiana Crespo Diaz, María del Carmen Barroso Alvarez, Ángel Casacó Parada, Bárbara Wilkinson Brito, Aymara Fernández Lorente, Liana Martínez Pérez, Elia Neninger Vinageras, Soraida Acosta Brooks, Mayelin Troche Concepción
Publikováno v:
World Journal of Surgical Oncology
Background The epidermal growth factor receptor (EGFR) signaling system is frequently unbalanced in human malignancies due to increased ligand production, receptor overexpression, receptor mutations, and/or cross-talk with other receptor systems. For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2afd42e876b757928bf18e33c3e72b9